SCHEMBL3405877

SCHEMBL3405877

CC1=C(C)C(C)C(CCCO)=C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3401498 0.94 LMNA (0.33)
SCHEMBL4663340 0.80 SKP2 (0.31)
SCHEMBL3405051 0.78
SCHEMBL3752202 0.75 HRH1 (0.34)
SCHEMBL4197781 0.75
Hydrochloric Acid SCHEMBL20583808 0.74 NOS3 (0.34)
SCHEMBL20583809 0.72 CHRM1 (0.35)
SCHEMBL7621644 0.71
SCHEMBL22783990 0.70
SCHEMBL15732578 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9097752-B2 Magnetic field probe sealed with a metallic plug KONINKLIJKE PHILIPS N.V. (NL) 2015-08-04 US claimed
EP-2820439-B1 MAGNETIC FIELD PROBE SEALED WITH A METALLIC PLUG KONINKL PHILIPS NV (NL) 2015-06-17 EP claimed
US-20150028871-A1 MAGNETIC FIELD PROBE SEALED WITH A METALLIC PLUG KONINKLIJKE PHILIPS N.V. (NL) 2015-01-29 US claimed
EP-2820439-A1 MAGNETIC FIELD PROBE SEALED WITH A METALLIC PLUG Koninklijke Philips N.V. (NL) 2015-01-07 EP claimed
US-8865924-B2 Compounds for use as ligands UNIVERSITY OF LEEDS (GB) 2014-10-21 US claimed
US-20130267725-A1 COMPOUNDS FOR USE AS LIGANDS UNIVERSITY OF LEEDS (GB) 2013-10-10 US claimed
WO-2013128355-A1 MAGNETIC FIELD PROBE SEALED WITH A METALLIC PLUG KONINKLIJKE PHILIPS N.V. (NL) 2013-09-06 WO claimed
US-8501829-B2 Compounds for use as ligands NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2013-08-06 US claimed
US-20100298457-A1 COMPOUNDS FOR USE AS LIGANDS NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2010-11-25 US claimed
EP-2252622-A2 COMPOUNDS FOR USE AS LIGANDS NPIL Pharmaceuticals (UK) Limited (GB) 2010-11-24 EP claimed
WO-2009093059-A2 COMPOUNDS FOR USE AS LIGANDS NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2009-07-30 WO claimed
US-9399211-B2 Microencapsulated catalyst-ligand system REAXA LIMITED (GB) 2016-07-26 US disclosed
US-20160030935-A1 MICROENCAPSULATED CATALYST-LIGAND SYSTEM REAXA LIMITED (GB) 2016-02-04 US disclosed
EP-2252622-B1 COMPOUNDS FOR USE AS LIGANDS UNIV LEEDS (GB) 2015-04-08 EP disclosed
US-8865924-B2 Compounds for use as ligands UNIVERSITY OF LEEDS (GB) 2014-10-21 US disclosed
EP-2252622-A2 COMPOUNDS FOR USE AS LIGANDS NPIL Pharmaceuticals (UK) Limited (GB) 2010-11-24 EP disclosed
US-20090221419-A1 Microencapsulated Catalyst-Ligand System REAXA LIMITED (GB) 2009-09-03 US disclosed
WO-2009093059-A2 COMPOUNDS FOR USE AS LIGANDS NPIL PHARMACEUTICALS (UK) LIMITED (GB) 2009-07-30 WO disclosed
EP-1993721-A1 MICROENCAPSULATED CATALYST-LIGAND SYSTEM Reaxa Limited (GB) 2008-11-26 EP disclosed
WO-2007096592-A1 MICROENCAPSULATED CATALYST-LIGAND SYSTEM REAXA LIMITED (GB) 2007-08-30 WO disclosed